Konact (Ketoconazole)

Ketoconazole belongs to the imidazole class of antifungals. It blocks the fungal enzyme lanosterol 14α‑demethylase, which is essential for producing ergosterol, a key component of the fungal cell membrane. Without ergosterol, the membrane becomes unstable, leading to leakage of cellular contents and ultimately fungal cell death.

The specific dosing regimen for Konact is determined by the prescribing healthcare professional based on the type and severity of the infection, the patient’s age, and the area of skin involved. Typically, a thin layer is applied to the affected area once or twice daily, but exact instructions should always follow the prescriber’s order.

Safety data for topical ketoconazole in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the use of Konact with their healthcare provider before starting treatment.

To order Konact, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team will provide pricing, availability, shipping details (including any cold‑chain requirements) and assist with import documentation.

Konact (ketoconazole) offers a broad spectrum of activity against dermatophytes and yeasts, similar to other imidazoles like clotrimazole. Compared with allylamine agents such as terbinafine, ketoconazole may have a slightly slower onset but is effective for seborrheic dermatitis and pityriasis versicolor where yeast overgrowth is prominent. Choice of therapy often depends on the specific infection, patient tolerance and prescriber preference.

Konact should be stored at room temperature, preferably below 25 °C. Keep the product in its original packaging to protect it from moisture and direct sunlight. Ensure the container is tightly closed when not in use, and keep it out of reach of children.

Konact is applied topically to clean, dry skin. A thin layer should be spread over the affected area and gently rubbed in. The medication is usually left on the skin and not rinsed off unless directed by a healthcare professional. Follow the prescriber’s instructions regarding frequency and duration of treatment.

While most reactions are mild, serious risks include severe allergic responses such as swelling, hives or anaphylaxis, extensive contact dermatitis, skin ulceration, and, rarely, systemic absorption leading to liver toxicity. Patients should discontinue use and seek medical attention if they experience any signs of a serious reaction.

Konact should not be used by individuals with a known hypersensitivity to ketoconazole or any other component of the formulation. It is also contraindicated on severely damaged, inflamed or broken skin, and should be avoided in patients with extensive liver disease if systemic absorption is a concern. Children under the age recommended by the prescriber should not use the product without medical advice.